•
Dec 25, 2021
Charles River Labs Q4 2021 Earnings Report
Charles River Labs reported strong Q4 2021 results, with revenue increasing by 14.4% and non-GAAP EPS increasing by 4.2%.
Key Takeaways
Charles River Laboratories International, Inc. reported Q4 2021 revenue of $905.1 million, a 14.4% increase year-over-year. GAAP EPS was $2.67, and non-GAAP EPS was $2.49. The company reaffirmed its 2022 guidance.
Revenue increased by 14.4% to $905.1 million.
GAAP earnings per share were $2.67, a decrease of 5.0%.
Non-GAAP earnings per share were $2.49, an increase of 4.2%.
The company reaffirms 2022 guidance.
Charles River Labs
Charles River Labs
Charles River Labs Revenue by Segment
Forward Guidance
The Company is reaffirming its 2022 financial guidance and expects to benefit from a continuation of the robust client demand that it experienced last year and price increases, which is expected to drive low-teens revenue growth in 2022.
Positive Outlook
- Revenue growth, reported 13.0% – 15.0%
- Revenue growth, organic 12.5% – 14.5%
- GAAP EPS estimate $9.20 – $9.45
- Non-GAAP EPS estimate $11.50 – $11.75
- Cash flow from operating activities ~$810 million
Challenges Ahead
- Contribution from acquisitions/divestitures, net (1) --
- Impact of 53rd week in 2022 ~(1.5%)
- Unfavorable/(favorable) impact of foreign exchange ~1.0%
- Acquisition-related amortization $1.90 – $2.10
- Other items (4) ~$0.10
Revenue & Expenses
Visualization of income flow from segment revenue to net income